Publication of the positive phase 2/3 clinical trial with masitinib in ALS in the journal ALSFD

08/07/2019 - AB Science announces the publication of the positive phase 2/3 clinical trial with masitinib in ALS in the journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.